OCUL
Ocular Therapeutix
$7.29
+$0.57 (+8.48%)Oct 28, 2026
Key metrics
The numbers that frame OCUL today
- Market cap
- $1.60B
- Gross margin
- 87.1%
- EV / Sales
- 20.8
- ROIC
- -301.3%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $6.00
- 52wk High
- $16.44
Growth
Revenue and earnings trend for OCUL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about OCUL
Is Ocular Therapeutix a good buy?
No. Ocular Therapeutix has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Ocular Therapeutix is selling at a very high price.
What is the market capitalization of OCUL?
Ocular Therapeutix's market capitalization is $1.60B.
What is the 52-week high for OCUL stock?
The 52-week high for Ocular Therapeutix is $16.44. The current close of $7.29 is 55.7% below that high.
What is the 52-week low for OCUL stock?
The 52-week low for Ocular Therapeutix is $6.00. The current close of $7.29 is 21.5% above that low.
Does OCUL stock pay dividends?
Ocular Therapeutix does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for OCUL?
Ocular Therapeutix's Debt / Equity ratio is 0.15.